From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Notice of Change of Auditors

Share the link to this page with others to keep them informed

OUTGOING AUDITOR: ASHM Health (ACN: 139 281 173) accepts the resignation of WALKER WAYLAND NSW and ASIC’s consent to this by email from ASIC dated 17th November 2023 approving such resignation.

INCOMING AUDITOR: ASHM Health (ACN: 139 281 173) announces that the ASHM Board is proposing to appoint Nexia Sydney Audit Pty Ltd as their incoming auditors at upcoming AGM on 27th November 2023 at 5.00PM AEDT.

REASONS FOR CHANGE: Rotation of auditors to promote independence.